SYRE logo

Spyre Therapeutics (SYRE) Accounts Receivable

Annual Accounts Receivable

N/A

31 December 2023

SYRE Accounts Receivable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Receivable

N/A

30 September 2024

SYRE Quarterly Accounts Receivable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SYRE Accounts Receivable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

SYRE Accounts Receivable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time

Spyre Therapeutics Accounts Receivable History

DateAnnualQuarterly
Mar 2021
-
$21.50 M(+787.7%)
Sept 2018
-
$2.42 M(-43.4%)
June 2018
-
$4.28 M(+26.9%)
Mar 2018
-
$3.37 M(+9.6%)
Dec 2017
$3.08 M
$3.08 M(+25.5%)
Sept 2017
-
$2.45 M(+102.1%)
June 2017
-
$1.21 M(+23.6%)
DateAnnualQuarterly
Mar 2017
-
$981.00 K(-19.3%)
Dec 2016
$1.22 M(-28.4%)
$1.22 M(-22.7%)
Sept 2016
-
$1.57 M(-3.3%)
June 2016
-
$1.63 M(+0.4%)
Mar 2016
-
$1.62 M(-4.7%)
Dec 2015
$1.70 M
$1.70 M(-59.9%)
Sept 2015
-
$4.24 M(+23.6%)
June 2015
-
$3.43 M

FAQ

  • What is the all time high annual accounts receivable for Spyre Therapeutics?
  • What is the all time high quarterly accounts receivable for Spyre Therapeutics?

What is the all time high annual accounts receivable for Spyre Therapeutics?

Spyre Therapeutics all-time high annual accounts receivable is $3.08 M

What is the all time high quarterly accounts receivable for Spyre Therapeutics?

Spyre Therapeutics all-time high quarterly accounts receivable is $21.50 M